• 沒有找到結果。

Increased risk of rheumatoid arthritis among patients with chronic osteomyelitis:a nationwide,population-based,cohort study

N/A
N/A
Protected

Academic year: 2021

Share "Increased risk of rheumatoid arthritis among patients with chronic osteomyelitis:a nationwide,population-based,cohort study"

Copied!
1
0
0

加載中.... (立即查看全文)

全文

(1)

Increased risk of rheumatoid arthritis among patients with chronic osteomyelitis: a nationwide, population-based, cohort study

Chien-Chung Huang1, Jiunn-Horng Chen1,Chun-Hung Tseng2, Chung-Y. Hsu3, Chih-Hsin Muo4, Chung-Ming Huang1, Po-Hao Huang1, Joung-Liang Lan1

1

Division of Immunology and Rheumatology, Department of Internal Medicine, China Medical University Hospital, Taichung, Taiwan

2

Department of Neurology, China Medical University Hospital, Taichung, Taiwan

3

Graduate Institute of Clinical Medical Science, China Medical University, Taichung, Taiwan

4

Management Office for Healthy Data, China Medical University Hospital and College of Medicine, Taichung, Taiwan

Abstract

Objective: To explore if there is a risk association between chronic osteomyelitis and the development of rheumatoid arthritis (RA).

Methods: From the Taiwan National Health Insurance Research Database, we identified 19374

hospitalized patients with newly diagnosed chronic osteomyelitis during 2000-2009, who were excluded with RA history before the initial diagnosis date (index date). We randomly selected 77496 sex-, age- and index date-matched patients without osteomyelitis history as the control group. Cox proportional hazard regressions were performed to estimate the association between chronic osteomyelitis and RA with adjustment of gender, age and comorbidities.

Results: The mean age of the selected 19374 hospitalized patients with newly diagnosed chronic

osteomyelitis was 55.8 years [standard deviation (SD) = 19.3]. The incidence of RA was twofold higher in the chronic osteomyelitis group compared with the non-osteomyelitis group (4.71 vs. 2.05 per 10000 person-years), with an adjusted hazard ratio (aHR) of 2.27 [95% confidence interval (CI) = 1.58-3.26]. The younger (< 45 years old) patients with chronic osteomyelitis had higher risk to develop RA with an aHR of 4.60 (95% CI 1.95-10.8). The risk of RA development increased when hospitalization twice or over twice per two follow-up years due to osteomyelitis with an aHR of 5.96 (95% CI 3.05-11.6) and 31.1 (95% CI 18.2-53.1), respectively.

Conclusion: This study demonstrated a significant association between chronic osteomyelitis and RA development. The younger patients with chronic osteomyelitis had higher risk of developing RA. This risk increased with the frequency of hospitalization due to osteomyelitis. Further studies are needed in the future.

參考文獻

相關文件

[14] reported that when patients with osteomyelitis of the jaws were divided into two groups, the ones undergo- ing BP treatment and the others taking no BP, Actinomyces

Purpose: The purpose of this study was to investigate computed tomography (CT) and clinical features relating to calcifications within the parotid gland of patients with

patients with stage I/II disease but not in those with stage III disease.43 A high serum level of VEGF is associated with poor survival among patients with small cell lung

Although altered taste is a rare symptom of vestibular schwannoma, this case illustrates the need for a high index of clinical suspicion when assessing patients with seemingly low

When case 2 in the present report is compared with those cases, the common findings are symptoms in relation to the condyle, absence of suppuration in relation to the

To evaluate the clinicopathologic features, prognostic factors, and management of patients in the North Chinese population with head and neck squamous cell carcinoma (HNSCC)

A case of SAPHO syndrome with dif- fuse sclerosing osteomyelitis of the mandible treated successfully with prednisolone

showed that 36% of patients with oral histoplasmosis had concomitant active pulmonary tuberculosis, 18% had malignant neoplasia, 9% had chronic obstructive pulmonary disease, and 9%